Clinical Trials Related Content

Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.

EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.

The São Paulo Government and Butantan Institute revealed that the Sinovac COVID-19 vaccine is 15.6% less effective than officials previously suggested.

The country has become the first in the world to approve the Sinovac COVID-19 vaccine, outside of China itself.

The projects will happen in 14 Member States and the United Kingdom, with 36 million in funding to get COVID-19 plasma to patients - boosting their immune response to the virus.

The approval of the Moderna COVID vaccine in the UK comes 2 days after European medical regulators, but not a moment too soon - the death toll continues to climb, standing at 78,508 currently.

The EMA joins the US in approving the 94.1% effective Moderna vaccine for use, while the UK still waits on further regulatory discussions.

Here, Mark Clements, MD PhD, paediatric endocrinologist, clinical investigator, and chief medical officer at Glooko Inc. takes part in a Q&A regarding his perspectives on remote clinical trials and data management tools.

Margaret Keenan, a 90 year old former jewellery shop assistant, becomes the first person to receive a COVID-19 vaccination in the UK.

The clinical trials are over for the Moderna vaccine - the company announced their drug was 94.1% effective and then filed for Emergency Use.

The Oxford and AstraZeneca vaccine trial gave an accidental half-dose to 3,000 people - but this mistake is the reason the vaccine acted as 90% efficient.

The UK's answer to Pfizer and Moderna, the Oxford and AstraZeneca vaccine, has proven to be exactly 70.4% effective against COVID-19.

Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.

New data from the Oxford COVID vaccine trial shows that the UK antidote is working well at Phase two, with defining percentages expected after Phase Three is complete.

Imperial College London are working on clinical trials of a kisspeptin drug that could treat PCOS, HA and other reproductive health problems.

Yesterday, at 6:45am in the US, the Pfizer vaccine was revealed to be over 90% effective - so when will the successful drug be available for the UK to use?

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, China charts how to deal with dementia during the COVID-19 pandemic, starting with a helpful global and regional overview.

Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.

Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores if digital twins are game-changers in clinical research and clinical care.

The University of Cambridge are developing a COVID-19 vaccine, which is expected to start clinical trials in Autumn 2020.